Status:
UNKNOWN
The Influence of Feeding Source on the Gut Microbiome and Time to Full Feeds in Neonates With Congenital Gastrointestinal Pathologies
Lead Sponsor:
Seattle Children's Hospital
Conditions:
Gastrointestinal Complication
Intestinal Obstruction
Eligibility:
All Genders
Up to 55 years
Phase:
NA
Brief Summary
This study explores the use of an exclusive human milk diet versus standard feeding practices to compare the influence on feeding outcomes and the gut bacteria in infants with intestinal differences.
Eligibility Criteria
Inclusion
- Infants with gastroschisis, giant omphalocele, intestinal atresia, mid-gut volvulus, hirschsprungs disease.
Exclusion
- Infant has already been on feeds
- Infants \<34 weeks gestation
- Parents with contraindications to providing milk (i.e. drug use-cocaine, fentanyl, meth BUT oxy/suboxone/marijuana OK)
- Complicated gastroschisis
- Short gut syndrome
- Additional congenital anomalies that affect ability to tolerate milk (i.e. cyanotic congenital heart disease BUT kidney disease ok)
Key Trial Info
Start Date :
June 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 9 2025
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT06072976
Start Date
June 9 2023
End Date
June 9 2025
Last Update
October 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seattle Children's Hospital
Seattle, Washington, United States, 98105